tert-Butyl 4-((1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate
97%
- Product Code: 118472
CAS:
1174020-64-4
| Molecular Weight: | 368.43 g./mol | Molecular Formula: | C₁₇H₂₈N₄O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30609552 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
This compound is primarily utilized in the development of beta-lactamase inhibitors, which are critical in combating antibiotic resistance. It serves as an intermediate in the synthesis of advanced pharmaceutical agents designed to enhance the efficacy of existing antibiotics. By targeting and inhibiting beta-lactamase enzymes produced by resistant bacteria, it helps restore the activity of beta-lactam antibiotics, such as penicillins and cephalosporins. Its role is significant in the formulation of combination therapies used to treat complex bacterial infections, particularly in healthcare settings where multidrug-resistant pathogens pose a serious threat.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Light-Yellow Powder Or Crystals |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $130.59 |
+
-
|
| 0.250 | 10-20 days | $261.18 |
+
-
|
tert-Butyl 4-((1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate
This compound is primarily utilized in the development of beta-lactamase inhibitors, which are critical in combating antibiotic resistance. It serves as an intermediate in the synthesis of advanced pharmaceutical agents designed to enhance the efficacy of existing antibiotics. By targeting and inhibiting beta-lactamase enzymes produced by resistant bacteria, it helps restore the activity of beta-lactam antibiotics, such as penicillins and cephalosporins. Its role is significant in the formulation of combination therapies used to treat complex bacterial infections, particularly in healthcare settings where multidrug-resistant pathogens pose a serious threat.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :